Overview and Scope
Contrast media injectors refer to medical devices that are used for injecting contrast media into the body to enhance the visibility of tissues for medical imaging procedures. It provides high accuracy, precision, and better outcomes during surgical procedures.
Sizing and Forecast
The contrast media injectors market size has grown strongly in recent years. It will grow from $1.6 billion in 2023 to $1.72 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increased incidence of chronic diseases, increased diagnostic imaging procedures, demand for minimally invasive procedures, expansion of healthcare infrastructure, growing aging population.
The contrast media injectors market size is expected to see strong growth in the next few years. It will grow to $2.32 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rise in interventional radiology procedures, increasing prevalence of cancer, focus on patient safety and comfort, globalization of healthcare services, regulatory support and compliance. Major trends in the forecast period include automation and connectivity, emergence of dual-head injectors, advancements in injector technology, focus on patient safety, rise in interventional radiology procedures, enhanced imaging techniques and modalities.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/contrast-media-injectors-global-market-report
Segmentation & Regional Insights
The contrast media injectors market covered in this report is segmented –
1) By Product: Consumables, Injector Systems, Accessories
2) By Type of Injectors: Single Head Injectors, Dual-Head Injectors, Syringe less Injectors
3) By Application: Radiology, Interventional Cardiology, Interventional Radiology
4) By End-user: Hospitals, Diagnostics Centers, Ambulatory Surgery Centers
North America was the largest region in the contrast media injectors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global contrast media injectors market report during the forecast period. The regions covered in the contrast media injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10187&type=smp
Major Driver Impacting Market Growth
Increasing cancer and cardiovascular disease (CVD) are expected to propel the growth of the contrast media injectors market going forward. Cancer is a condition that occurs when body cells grow out of control and spread to other body regions. Cardiovascular disease refers to a type of disease that affects the heart or blood vessels. Contrast media injectors are applied while diagnostic imaging to enhance image quality and patient safety and improve blood flow and tissue perfusion. For instance, in January 2023, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth of 3.16%. , Furthermore, in April 2023, according to the World Heart Federation, a Switzerland-based non-governmental organization, over 500 million individuals worldwide will remain impacted by cardiovascular diseases. These conditions led to 20.5 million fatalities in 2021, representing nearly one-third of the total global mortality and reflecting a notable rise from the previously estimated 121 million deaths attributed to cardiovascular diseases. Therefore, increasing cancer and cardiovascular disease (CVD) are driving the growth of the contrast media injectors market.
Key Industry Players
Major companies operating in the contrast media injectors market report are The Bracco Group, Bayer AG, Medtron AG, Ulrich GmbH And Co. KG, General Electric Company, Nemoto Kyorindo Co. Ltd., Guerbet Group, Sino Medical-Device Technology Co. Ltd, Apollo RT Co.Ltd, Shenzhen Anke High-tech Co. Ltd, Hilin Life Products Inc., Sanofi S.A, Novartis AG, Vivid Imaging, AngioDynamics. Inc., Taejoon Pharmaceutical Co. Ltd., Hong Kong Medi Co Limited, Medrad Inc., TaeWoong Medical Co. Ltd., Medtronic Plc, Covidien, ACIST Medical Systems, Boston Scientific Corporation, Mallinckrodt Pharmaceuticals, Lantheus Medical Imaging Inc., Imaxeon Pty Ltd., Nano-Ditech Corp.
The contrast media injectors market report table of contents includes:
1. Executive Summary
2. Contrast Media Injectors Market Characteristics
3. Contrast Media Injectors Market Trends And Strategies
4. Contrast Media Injectors Market – Macro Economic Scenario
5. Global Contrast Media Injectors Market Size and Growth
.
.
.
31. Global Contrast Media Injectors Market Competitive Benchmarking
32. Global Contrast Media Injectors Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Contrast Media Injectors Market
34. Contrast Media Injectors Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
